Alpha Market Capitalization from 2010 to 2024
| DRTS Stock | USD 2.80 0.06 2.10% |
Check Alpha Tau financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alpha Tau's main balance sheet or income statement drivers, such as Tax Provision of 15.2 K, Net Interest Income of 5 M or Interest Income of 5.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.59. Alpha financial statements analysis is a perfect complement when working with Alpha Tau Valuation or Volatility modules.
Alpha | Market Capitalization |
Latest Alpha Tau's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Alpha Tau Medical over the last few years. It is Alpha Tau's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alpha Tau's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 196.29 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Alpha Market Capitalization Regression Statistics
| Arithmetic Mean | 552,750,200 | |
| Geometric Mean | 506,635,407 | |
| Coefficient Of Variation | 35.87 | |
| Mean Deviation | 173,634,708 | |
| Median | 682,976,231 | |
| Standard Deviation | 198,255,520 | |
| Sample Variance | 39305.3T | |
| Range | 480.9M | |
| R-Value | (0.83) | |
| Mean Square Error | 13138.4T | |
| R-Squared | 0.69 | |
| Significance | 0.0001 | |
| Slope | (36,813,922) | |
| Total Sum of Squares | 550273.5T |
Alpha Market Capitalization History
About Alpha Tau Financial Statements
Alpha Tau shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Alpha Tau investors may analyze each financial statement separately, they are all interrelated. The changes in Alpha Tau's assets and liabilities, for example, are also reflected in the revenues and expenses on on Alpha Tau's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel. Alpha Tau is traded on NASDAQ Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.